Notice of Intent to Award a Sole Source Contract to Hitachi

The Food and Drug Administration (FDA), under the Department of Health and Human Services, plans to award a sole source firm-fixed price commercial Purchase Order to Hitachi. This contract, associated with solicitation number FDA-133701, involves procurement activities aligned with NAICS code 334516. The notice was posted on June 4, 2026, with a response deadline of June 19, 2026, reflecting the agency's intent to bypass competitive bidding and directly engage Hitachi for the specified work. The place of performance is identified as Cincinnati, Ohio, and the contract is managed out of the FDA's office in Rockville, Maryland. No set-aside or special participation categories are applicable to this procurement. For further inquiries or communications, Janice Heard serves as the primary point of contact. The sole source designation indicates the FDA has determined that Hitachi is the only responsible source capable of fulfilling the requirements outlined in the notice.